Globe Roche Logo

World AIDS Day – December 1st, 2016

Join us in observing World AIDS Day on December 1st and show your support and solidarity with the millions of people living with HIV.

As the leading provider of HIV early infant diagnosis and viral load testing, Roche has a social responsibility to continue providing access to quality HIV diagnostic testing. Join us in observing World AIDS Day on December 1st and showing your support and solidarity with the millions of people living with HIV.


A community, and a commitment

In the fight to suppress HIV and stamp out AIDS, the global community has made tremendous progress. Head of Business Unit Molecular Diagnostics, Roche Diagnostics, Dr. Uwe Oberlaender joined an expert panel to discuss what else can be done in order to hit the UNAIDS 90-90-90 target.

Read the interview


 

HIV/AIDS: a persistent challenge

In 2015, 1.1 million AIDS-related deaths occurred, equating to some 3,000 AIDS-related deaths per day.1

According to UNAIDS, a joint program of the United Nations, 17 million people living with HIV were accessing antiretroviral therapy worldwide in December 2015. In the areas hardest hit by HIV, however, that corresponded to only 28%.2

 


 

Working towards an AIDS-free generation

In July 2014,3 UNAIDS announced their ultimate goal to end AIDS by 2030. This announcement is backed by the ambitious 90-90-90 target, which outlines a strategy to bring us closer to that goal by the year 2020.

diagnosed ...of people living with HIV know their HIV status
on treatment ...of people who know their status receive treatment
virally suppressed ...of people on HIV treatment have a suppressed viral load

Roche’s role in achieving the UNAIDS target

In September 2014, Roche announced the launch of the Global Access Program, created with UNAIDS and other partner organizations. Since then, Roche has committed to increasing access to HIV diagnostics for qualifying organizations in 82 eligible countries.

Within the framework of the Global Access Program, 1.5 million infants were tested for HIV in 2015 with Roche assays. In 2016, newer high-throughput automated systems were incorporated to enable further scaling up.


“This agreement with Roche Diagnostics is a powerful step towards ending the unconscionable failure of the world to meet the treatment needs of children living with HIV. We now need to use this agreement to rapidly scale up diagnostic and treatment services for all children living with HIV, in line with the 90-90-90 target.”  –  UNAIDS Executive Director Michel Sidibé

GAP

 

References:

  1. http://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-numbers-2016_en.pdf Accessed September 21, 2016
  2. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf Accessed September 21, 2016
  3. http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2014/july/20140723dai Accessed September 21, 2016
  4. UNAIDS Core Epidemiology Slides, July 2015. www.unaids.org/sites/default/files/media_asset/20150714_epi_core_en.pdf Accessed June 13, 2016
  5. UNAIDS Report on the global AIDS epidemic. 2010. www.unaids.org/globalreport/HIV_prevalence_map.htm Accessed June 13, 2016
  6. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. 2014.